Marking its ten-year anniversary in January, the Global Fund to Fight AIDS, Tuberculosis and Malaria has provided HIV treatment to 3.3 million people, tuberculosis treatment to 7.7 million, and malaria treatment to more than 230 million worldwide. The Fund has disbursed more than $14 billion in grants to 150 countries, and is credited with saving more than six million lives.
U.S. Department of Health and Human Services issues new guidelines recommending treatment for all adults and adolescents living with HIV, regardless of CD4 count or viral load.
The FDA approves the first at-home HIV test that enables people to learn their HIV status right away.
The FDA approves the use of Truvada for pre-exposure prophylaxis (PrEP). HIV-negative adults who are at risk for infection can take this medication to reduce their risk of acquiring HIV.
The 19th International AIDS Conference (AIDS 2012) is held in Washington, DC—the first time since 1990 that the conference has been held in the United States. Conference organizers had refused to convene the event in the U.S. until the federal government lifted the ban on HIV-positive travelers entering the country.
